All Pharma News
CytRx guns for a reset, rebranding as LadRx

CytRx guns for a reset, rebranding as LadRx
Ben Adams FIERCEPHARMA
26 Sep 2022
Share Share
CytRx Corporation Relaunches as LadRx Corporation

CytRx Corporation Relaunches as LadRx Corporation
BUSINESSWIRE
23 Sep 2022
Share Share
CytRx Announces Distribution of Series D Preferred Stock to Holders

CytRx Announces Distribution of Series D Preferred Stock to Holders
BUSINESSWIRE
19 May 2022
Share Share
CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.

CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.
BUSINESSWIRE
17 May 2022
Share Share
CytRx Partners with Oncology Development Expert to Advance LADR Platform

CytRx Partners with Oncology Development Expert to Advance LADR Platform
BUSINESSWIRE
20 Apr 2022
Share Share
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress

CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
BUSINESSWIRE
21 Mar 2022
Share Share
CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma

CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma
BUSINESSWIRE
09 Mar 2022
Share Share
Orphazyme to assess strategic options after EU advisers nix drug

Orphazyme to assess strategic options after EU advisers nix drug
BIOSPACE
25 Feb 2022
Share Share
CytRx Highlights Orphazyme`s Update on Planned NDA Resubmission for Arimoclomol

CytRx Highlights Orphazyme`s Update on Planned NDA Resubmission for Arimoclomol
BUSINESSWIRE
14 Feb 2022
Share Share
CytRx Highlights ImmunityBio`s Use of Aldoxorubicin in Various Forms of Cancer

CytRx Highlights ImmunityBio`s Use of Aldoxorubicin in Various Forms of Cancer
BUSINESSWIRE
21 Dec 2021
Share Share